Global Interventional Cardiology Devices Market Growth (Status and Outlook) 2023-2029

Global Interventional Cardiology Devices Market Growth (Status and Outlook) 2023-2029

Interventional cardiology is numerous non-surgical processes for treating cardiovascular related problems. These procedures use flexible tubes and catheters thin to get way inside blood vessels to perform diagnostic test or to repair heart structures or other damaged vessels, often evading the need to have a surgical operation. Several devices used in these procedures include stent, PTCA balloon and catheters among several others. The diseases that are treated using interventional cardiology comprise coronary artery diseases, peripheral vascular disease and heart valve disease mainly.

LPI (LP Information)' newest research report, the “Interventional Cardiology Devices Industry Forecast” looks at past sales and reviews total world Interventional Cardiology Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Interventional Cardiology Devices sales for 2023 through 2029. With Interventional Cardiology Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Cardiology Devices industry.

This Insight Report provides a comprehensive analysis of the global Interventional Cardiology Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interventional Cardiology Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Interventional Cardiology Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Cardiology Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Cardiology Devices.

The global Interventional Cardiology Devices market size is projected to grow from US$ 8392.4 million in 2022 to US$ 11630 million in 2029; it is expected to grow at a CAGR of 4.8% from 2023 to 2029.

Growth in geriatric population is expected to boost the market growth in the near future. Moreover increasing coronary artery disease is presumed to further propel the industry growth over the next eight year period Rise in demand for minimal procedures related with invasive angioplasty. Research and development across the world for technological advancement in order to achieve competitive advantage is estimated to further fuel the market demand over the forecast period. Development and innovation in interventional cardiology has resulted in increased efficiency thus is presumed to be a major factor to fuel the market demand over the next seven years period.

This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Cardiology Devices market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Angioplasty Balloons
Angioplasty Stents
Catheters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices

Segmentation by application
Hospitals
Ambulatory Surgical Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Acrostak
B. Braun Melsungen
Biosensors International
Boston Scientific Corporation
Cordis Corporation
Edwards Lifesciences Corporation

Please note: The report will take approximately 2 business days to prepare and deliver.